Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionPACIFIC SELECT FUND - Small-Cap Index Portfolio Class I
Latest Disclosed Ownership29,991 shares
Latest Disclosed Value $ 742,577
PACIFIC SELECT FUND - Small-Cap Index Portfolio Class I ownership in CPRX / Catalyst Pharmaceuticals, Inc.

On May 27, 2026 - PACIFIC SELECT FUND - Small-Cap Index Portfolio Class I filed a NPORT-P form disclosing ownership of 29,991 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $742,577 USD as of March 31, 2026. The entity filed a previous NPORT-P on February 18, 2026 disclosing 29,991 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $944,417 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-27 2026-03-31 NP Catalyst Pharmaceuticals EC US14888U1016 29,991 0 0.00 743 6.15 0.0966
2026-02-18 2025-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 29,991 -1,067 -3.44 700 14.40 0.0928
2025-11-25 2025-09-30 NP Catalyst Pharmaceuticals EC US14888U1016 31,058 0 0.00 612 -9.21 0.0816
2025-08-18 2025-06-30 NP Catalyst Pharmaceuticals EC US14888U1016 31,058 1,967 6.76 674 -4.54 0.0987
2025-05-28 2025-03-31 NP Catalyst Pharmaceuticals EC US14888U1016 29,091 -174 -0.59 705 15.57 0.1126
2025-02-27 2024-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 29,265 -3,713 -11.26 611 -6.87 0.0863
2024-11-25 2024-09-30 NP Catalyst Pharmaceuticals EC US14888U1016 32,978 1,812 5.81 656 35.89 0.0819
2024-08-12 2024-06-30 NP Catalyst Pharmaceuticals EC US14888U1016 31,166 0 0.00 483 -2.82 0.0657
2024-05-29 2024-03-31 NP Catalyst Pharmaceuticals EC US14888U1016 31,166 3,144 11.22 497 5.31 0.0654
2024-02-21 2023-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 28,022 1,401 5.26 471 51.45 0.0675
2023-11-29 2023-09-30 NP Catalyst Pharmaceuticals EC US14888U1016 26,621 0 0.00 311 -12.89 0.0506
2023-08-24 2023-06-30 NP Catalyst Pharmaceuticals EC US14888U1016 26,621 0 0.00 358 -19.05 0.0545
2023-05-26 2023-03-31 NP Catalyst Pharmaceuticals EC US14888U1016 26,621 0 0.00 441 -10.91 0.0694
2023-02-24 2022-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 26,621 0 0.00 495 45.16 0.0768
2022-11-29 2022-09-30 NP Catalyst Pharmaceuticals EC US14888U1016 26,621 -1,843 -6.47 342 71.36 0.0556
2022-08-25 2022-06-30 NP Catalyst Pharmaceuticals EC US14888U1016 28,464 0 0.00 200 -15.32 0.0307
2022-05-27 2022-03-31 NP Catalyst Pharmaceuticals EC US14888U1016 28,464 0 0.00 236 22.40 0.0297
2022-02-15 2021-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 28,464 0 0.00 193 28.00 0.0225
2021-11-26 2021-09-30 NP Catalyst Pharmaceuticals EC US14888U1016 28,464 0 0.00 151 -7.98 0.0180
2021-08-17 2021-06-30 NP Catalyst Pharmaceuticals EC US14888U1016 28,464 0 0.00 164 24.43 0.0187
2021-05-28 2021-03-31 NP Catalyst Pharmaceuticals EC US14888U1016 28,464 -5,377 -15.89 131 15.93 0.0155
2021-02-09 2020-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 33,841 0 0.00 113 13.00 0.0142
2020-11-27 2020-09-30 NP Catalyst Pharmaceuticals EC US14888U1016 33,841 0 0.00 101 -35.90 0.0156
2020-08-19 2020-06-30 NP Catalyst Pharmaceuticals EC US14888U1016 33,841 0 0.00 156 20.00 0.0247
2020-06-01 2020-03-31 NP Catalyst Pharmaceuticals EC US14888U1016 33,841 3,509 11.57 130 15.04 0.0251
2020-02-11 2019-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 30,332 0 0.00 114 -29.81 0.0160
2019-11-27 2019-09-30 NP Catalyst Pharmaceuticals EC US14888U1016 30,332 30,332 161 0.0244
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.